Fosdevirine

DB06166InvestigationalSmall molecule

Investigated for use/treatment in HIV infection and acquired immune deficiency syndrome (AIDS) and aids-related infections.

Chemical structure of Fosdevirine
Primary indication
Investigated for use/treatment in HIV infection and acquired immune deficiency syndrome (AIDS) and aids-related infections.Curator reviewed
Formula / weight
C20H17ClN3O3P · 413.8 g/mol (avg)
Code names
GSK-2248761 · GSK-2248761A · IDX-899

Resolves to

Compound
UNIIZ4I0C281BJCAS1018450-26-4ChEMBLCHEMBL3781845
Structure
InChIKeyCGBYTKOSZYQOPV-CCEZBSFNSA-NSMILESCO[P@](=O)(C1=C(NC2=CC=C(Cl)C=C12)C(N)=O)C1=CC(C)=CC(\C=C\C#N)=C1
Targets
P03366gag-pol

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Fosdevirine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In